Clinical Trials Browser

Phase 3 × Completed × pyrotinib × Clear all

NCT04447118 2025-12-19

PYRAMID-1

Phase 3 Completed

Non-squamous NSCLC

NCT03588091 2025-08-22

Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer

Phase 3 Completed

HER2-positive Breast Cancer